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Variable,n Eventa, n Ibg rank event
(predictivevalue) analysis,p
ST-deoreeeionin baseline ECG, n = 59 14 (0.24) 0.0003
TnT >’0.1 J@L, n = 246
Myoglobin>60 L@/L,n = 117
TnT >0.1 L@L or Mycglobin>60 y@L, n = 262
ST-depressionorTnT >0.1 @L, n = 256
ST-depressionor Myoglobin>60 j@L, n = 145
TnT >0.1 L@/Lend Myoglobin>80 #g/L, n = 101
ST-depressionand TnT >0.1 jLglL,n =47
ST-deoreseionand Mvodobin >60 wtlL, n =31
ST-dep;ess. orTnT o~M~oglobin,n =>72
31 io,13j
16 (0.15)
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34 (0.13)
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Conclusion: Early measurements of Myoglobin and TnT carry indepen-
dent prognostic information in patients with unstable corona~artery disease.
The combination of these biochemical markers of ischemia and the ECG
identifies a subgroup at high risk for auffering early cardiac events. However,
the ECG is still the best individual predictor of peer outcome.
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Stratification of Patiants with Unstable Angina
A.A. Awan, L.D. Gillam, R. Goldman, T. Shuaib, Z. Mirza, J. Quion,
A. LaSala, D. Waters, C. Chen. f-ksr?fordFfospita/,Harlford, CT USA
Toaseesethesafety and utility of dobutamine stress echocardiography (DSE)
forriskstratification of patients (pts) with unstable angina. Thiestudy included
109 pts (age: 61 +12 yeara, 57 males) with admission diagnosis of unstable
angina, in whom DSE was performed after stabilization of symptoms for at
leaat 24 houra. Pts were followed for 1-2.5 yeare. Results: DSE caused
no major complications (death, infarction or arrhythmia requiring treatment).
DSE was positive for ischemia in 68 pts and negative in 41 pts. During
follow-up, there were 7 pte with cardiac deathe/fatal infarctions, 32 rehos-
pitalization for recurrent angina, myocardial infarction an~or congestive
heart failure, and 21 revascularizations (19 surgical, angioplasty = 2). One of
the 41 pts with negative DSE had recurrent angine/congestive heart failure
leading to readmission to a hospital for revascularization without any death
during follow-up. In contrast, in 6S pts with a poeitive DSE, 7 pts died (p
< 0.05), 20 pts underwent revascularization (p < 0.01) and 31 pts required
hospital readmission with recurrent chest pain, infarction and/or congestive
heart failure (p < 0.01). Negative predictive value of DSE for cardiac event,
revascularization or readmission was 97.6% and positive predictive value
was 57% with accuracy of 72%.
Cpnc/uaions: In unstable angina pts whose symptoms have been stabi-
lized for at least 24 hours, DSE appeara safe. A positive responee indicative
of ischemia occurs in about two thirds of caees and accurately predicted
cardiac death, recurrent events requiring hospitalization and/or revascular-
ization during 1-2.5 years of follow-up. In contrast, a negative DSE is highly
predictive of a benign outcome.
D991 15 Prahoapital Troponin TTeet in Patienta WithSuspeoted Acute Myocardial Infarction
A. Schuchert, C. Harem, J. Scholz, S. Klimmeck, B. Goldmann, T. Meineitz.
Depsr?.of Cardiology, UKE, Hamburg, German& Depart. of Anesthesiology,
UKE, Hamburg, Germany
Cardiac troponin T (TnT) is an early marker for acute myocardial infarction
(AMI). We investigated whether a rapid qualitative assay for the detection of
serum cardiac TnT (TROPTR)(detection limit 0.18 rig/ml) in the ambulance
car helps to verify AMI very earfy in 158 patients (pts) with suspected AMI
(male n = 93;89•13 years). A 2nd TnT-test wae performed within 3 hours
after admission to the emergency room of a hospital. An AMI was defined
either by new Q-waves or new negative T-waves in the ECG combined with
an increase of CK > 150 WI and an increaee of CK-MB =- 6Y0.An AMI
wae excluded in the absence of these findings. Combined studied endpoints
were death or definitive AMI from 2nd day in-hospital until 6 month follow-up.
Follow-up included 153 pts.
Results: There were 40 pts with AMI, 118 pte without AMI. Prehospital
TnT-test was positive in 7 pts with AMI (18%) and in 4 without AMI (3%).
The second test at hospital admission was positive in 39 pts with AMI. In pts
without AMI the 2nd test was positive in 14 (12%) and negative in 104 (88%)
pts. In the latter group 5 pts were lost from follow-up. In pts without AMI,
cardiac events within the next 6 months occurred more offen in pts with a
positive (n= 7/14) than in pts with a negative TnT-test (n = 16/99; p c 0.05).
Conclusions: The prehospital TnT-test was positive in only the minority
of the pte with AMI. The second TnT-test at hospital admission detected in
WOA the pts with AM]. Pts in whom an AMI was excluded, but with afJOSitiVO
TnT-teet at hospital admission, had an increased risk for death or AMI within
the next 6 monthe.
[991-161lndaPsndentLong-Term pro9nosticVa,ueof
Troponin Tfor Cardiac Outcomea Aftar Noncardiac
Surgary
F. Lopez-Jimenez, L. Goldman, E.J. Thomas, P.Johneon, K.M. Kuntz,
D.B. Sacks, T.H, Lee. Brigham and Women’s Hospital, Boston, MA, USA,
UCSE San Francisco, CA, USA
Toevaluatethe6-month prognostic significance of abnormal troponin T (TnT)
serum levels, we etudied 772 patients (49% female, mean age 66.7 + 11
years) who underwent rnsjor noncardiac surgery without major cardiac com-
plications. Clinical data were obtainad preoperatively via a structured history
and physical examination. The protocol for measurement of total serum cre-
atine kinase (CK), CK-MB and TnT included samples in the recovery room
and on the following two mornings. Six-month follow-up data on vital status
and clinical complications were collectad via interview for 722 (94%) pa-
tients. A search of the Massachusetts Registry of Deaths was performed to
confirm death and to search for patients lost to follow-up. Classification of
cause of death and major cardiac complications was performed by reviewers
blinded to TnTand CK-MB values. Abnormal values of TnT (z-O.1rig/ml) and
CK-MB (>8 U/L with ion-exchange chromatography assay or >5 ng/mL for
mass assay) were detected for 92 (12%) and 211 (27%) patients, respec-
tively. During the six-month follow-up period, 19 (2.5%) patients had major
cardiac complications, including 14 cardiac deaths, 3 non-fatal myocardial
infarctions and 2 admissions for unstable angina. Elevated Tn? values were
detected for 8/19 patients with complications (sensitivity = 42%; specificity
= 89%; positive predictive value [PV+] = 9%; PV– = 98%; relative risk =
5.4). For CK-MB, corresponding test characteristics were 32%, 73%, 3%,
98%, and 1.2, respectively. Multivariate analysis indicated that TnT was an
independent correlate of outcome after adjusting for preoperative clinical and
CK-MB data. This correlation was a function of the relationship of elevated
TnT levels with postoperative inhospital heart failure and arrhythmias. These
data suggest that TnT elevations may reflect ischemia that did not lead to
CK-MB elevations.
/991-171 MinirnalElevation of TropOninlonAdrnisaion
Identifies Patienta at Risk for Adverae Cardiac
Outcomes
R.L. Jesse, M.C. Kontos, D.J. Zhang, J.P. Ornate, J.L. Tatum, P.Anderson.
Medical College of ViginiaWCU, Richmond, VA, USA
Itis unknown whether minor elevations in Troponin I (Tnl) areassociated with
an increased incidence of adverse cardiac evants. Methods: We measured
cardiac Tnl in the admission blood sample from 466 patients (pts) admitted
for poesible myocardial infarction (Ml). Ml was diagnosed by conventional
criteria. Results: Of 466 pts studied, 67 Nled-in for ML Tnl was 22.0 ng/mL
(lower limit for Ml) in 62 pts, ”including 76% with ML In 21 pts Tnl was ?1.0
but <2.0 ngfmL, including 29% having ML Only 10 of the 463 pts (2.2%) with
Tnl <1.0 ng/mL had Ml. A total of 132 pts (29%) had cardiac eventa (Ml,
revascularization or death). Number of events and relative risks (compared
to pts with Tnl < 1.0) are shown in the Table.
Tnl lna/mL) N Cardiac Events Relative Risk
22.0 62 55 (89”A) 38
1,0s Tnl <2.0 21 11 (53%) 5.3
< 1,0 363 66 (17”/4 1.0
Adverse cardiac events were significantly higher in pte with Tnl ? 2.Othan
in pts havingeither intermediate (p <0.001) or low (p <0.0001) Tnl. However,
the event rate in pts with intermediate Tnl was significantly higher than in
pts with low Tnl (p < 0.001). Conclusion: At the time of admiseion, minor
elevations of Tnl that are leas than the defined Ml threshold are associated
with an increased incidence of adverse cardiac events.
D991 18 Noninvaaive Tests After Myocardial Infarction in
tha Thrombolytic Era: Prognostic Valua and
Ralative Cost
R.F.E.Pedretti, O. Catalano, S.S. Braga, R. Tramarin. Sa/vatore Maugeti
Foundation, Care and Reaearch hrstitute, Cardiology Dpt, Rehabilitation
Institute, Tradate, Italy
The prognostic value and relative cost of noninvasive tests after Ml was
evalusted in 536 consecutive patients, 263 (53%) treated with thromboly-
sis, eligible for cardiac rehabilitation. At 2-year follow-up, 26 (5%) pts died
from cardiac death. Cox regression analysis selected variables to build prog-
nostic models and the model predictive accuracy was evaluated by logistic
regression and receiver-operator characteristic curve area (ROCca). Costs
of noninvasive tests, relative to that of a resting ECG, were obtained from
literature.
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PrognosticModel ROC Ca Sens. Spec. cost
Onlv clinicalvariebles (CV) 0.79 0.42 0.95 -
CV; SDNN <50 ms & 24-h Helter 0.79 0.42 0.98 6
CV+ QRS >110 mson SAECG 0.82 0.79 0.71 1.5
CV + USVTon 24-h Helter 0,s4 0.63 0.65 6
CV + LVEF <0.40 cm2d-echo 0.64 0.68 0.62 7.7
CV + exercise test (ET) vsriebles 0.87 0,74 0.90 5
CV + ETvsrtables + LVEF <0.40 0.88 0,74 0.93 12.7
CV + ET vsrfablee+ QRS >110 ms 0.89 0.68 0.96 6.5
When a single diagnostic test was added to CV (previous Ml, age =-60
yra, thrombolysis), ET variablea (no eligibility to ET, ET interruption because
of dyspnea or pressure drop, ST depression 23 mm and peak systolic
preseure <145 mmHg) provided the greateet prognostic information. When
a 2nd diagnostic test wae added to CV and ET, LVEF on 2d-echo or QRS
duration on eignal-avareged ECG (SAECG) had slight but still significant
additional prognostic value while Helter variables did not. After Ml in the
thrombolytic era no more than 2 noninvasiveteste (ET+ 2d-echo or SAECG)
are requirad for riak stratification. Combinsd uee of ET and SAECG was the
moat cost-effective stratification strategy.
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Correlates with Adaquate Pslmaz-Schatz Stent
Deployment: Is High Preaaure Inflation Necessary?
K. Fujise, M.S. Ganim, A. Pathan, R.L. Kirkiedee, Y.Stewart, G.W. Schroth,
R.W. Smalling. Urriversityof Texas-HoustonHealth Scierrce Cerrtec
Houston, TX, USA
Backgrourrd:Although high pressure inflation after Palmsz-Schatzstent (PS)
implantation has been amployed to achieve optimal atentdeployment, it is not
clear whetherthia ie due to bigger balloon size or more radial force generated
by high pressurs inflation. A4ethods:ThhWtwoPatients (33arterial aegments)
who undarwent PS implantation and intravascular ultrasound (IVUS) were
atddied. In each case, on-line QCA data was used to aelect the best size
balloon for peat-stent inflation. Final inflation pressure (IP) was left to the
operatora’ discretion. After PS implantation and poet-stent inflation, IVUS
was parformed to measure the vessel dimensions and assess the adequacy
of stent deployment by several indices including relative stent expansion
(RSE = Stent cross eactional aredMean reference Iuminal area, reported
in parentage). Results: IP and balloon to artery ratio (BAR) ranged widely
from 4 to 22 atms (Mean = 14.7 + 0.6 atms, SE) and 0.73 to 1.31 (Mean =
1.03 + 0.02 mm), respectively. Reeultant RSE also vaied widely from 44.0
to 141.7% (Mean = 86.7 + 3.9%), representing poor to god deployment.
Stepwise linear regression analysis revealed that RSE is correiatsd most
strongly with BAR (Fig. 1A, Correlation coefficient = CC = 0.76, p < 0.0001),
but not with IP (Fig. IB, CC = 0.13, p < 0.1).
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Conclusions: BAR is the most criticsl determinant of adequate stent de-
ployment. IP may not be impatant to achieve adequate stent deployment as
long as an adequate BAR is maintained.
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Effact of High Pressura Balloon Dilation Upon tha
DeDlovment of Different Coronarv Stents - An In
Vit;o Study Uaing Diract Magnification
Radiography
T, Poerner, W. Voelker, J. Teubner, P. Gaudron, K.-P. Jungius, D. Liepsch,
d. Ertl. Depsrtrnent of Cardio/ogyand Radio/ogy oftha University
Mannheim, Haidelbarg, Germany, Department of Cardio/ogyand Radiol~,
T?chnical University Munich, Germany
It is well known that high preasure balloon dilation results in a further increase
of both.lumen diameter and croes-sactional area of coronary stents. Aim of
this study was to compare three second generation stent typea [Johnson
& Johnson Cordis PS 154A (PS), ACS Multi Link (ML) and Scimed NIR]
regarding the influence of the inflation preseure upon the etent expansion and
to estimate their acute recoil. The stents were implanted with 6 Bar in silicone-
rubber tubes of 3.2 mm diameter and concentric narrowing with compliance
simulating a rigid and elastic coronary stenosis. Successive dilations were
then performed using a non-compliant 3.5 mm balloon with 9, 12, 15, 16 and
21 Bar.Thestents were scanned after each dilation using direct magnification
radiography, which provides a 0.03 mm spatial resolution and ie therefore
accepted as a gold standard in vitro. The minimal lumen diameter (MLD) and
the calculated stent recoil (recoil = 1- MLDiinflated balloon diameter) were
determined for each dilation step and expreased as mean & SD. Statistical
analysis was performed using atwo-tailad Studant ttest with 95% confidence
interval.
Stent n MLD (mm) ‘A Recoil
9 Sar 21 Sar P e Sar 21 Ser P
ML 3 3.23 + 0.14 3.29 + 0.06 ns. 11 * 5% 13• 2“A n.s.
NIR 3 3.15 + 0.12 3.29 + 0.07 n,s. 16 + 30/n 16+ OO/. n.s,
Ps 3 2.99 + 0.13 3.10 * 0.17 n.s. 19 * 34A 19* 4% n.s,
In this stenotic model high pressure balloon dilation (>9 Bar) failed to
increase significantly the MLD of all stents. However, NIR and Multi Link
had a significant larger MLD than Palmaz-Schatz at each dilation atep (P <
0.001) due to their lower recoil, which proves the higher radial strength of
these stent types.
-] sideBran.h~cc,usion~o,,owin9Hi9hpre~u~e
Coronary Stanting: Incidance and Angiographic
Predictor
D. Aliabadi, R.D. Safian, F.V.Tilli, T.R. Bowers, C.L. Grines, J.A. Goldetein,
M. Spybrook, W. O’Neill. kVi//iamBeaumont Hospital, Royal Oak, Michigan,
USA
To delineate predictors of side branch occlusion (SBO) in the era of high
pressurestenting weanalyzad 331 consecutive angiograms for the presence
of side branches (SB)’greaterthan 1 mm covered by coronary atents. 224 SB
in 181 Ieeionscovered by 324 etente (270 PS, 54 GRI) were characterized.
SBO(TIMI Iflow)occurred in43(19%). Two(5%)oocluded after predilatation,
12 (28%) after stent deployment, 29 (67Yo)after post stent dilatation using
high pressures (15 + 3ATM). Noclinicsl characteristics correlated with SBO.
SBOn. 43 No S60 n = 181 p value
Threatened SB 28 (650/o) 7 (4%) <0,01
Ulceration 21 (49%) 47 (26%)
Dissection(any)
0.05
17 (390A) S3 (46%) 0.14
Stent Design 34 (79%) 142 (76%) 0.93
Restenoticlesion 16 (37%) 35 (19YO) 0.27
Sailoutstent 7 (16%) 27 (15%) 0.85
SB Diameter (mm) 1,66* 0,44 1.70 * 0,39 0.66
By multivariate analysis, threatened SB morphology (defined as those
SB with greater than 50Y0 narrowing at the origin arising from within the
diseased portion of the target lesion) remained a predictor of SBO (OR 21
[6-50, 95% Cl], p c 0.0001). Conclusion: The incidence of SBO after high
preesure stenting is 19%. Most SBO occur after post atent dilatation ueing
high pressures. Threatened SB morphology ia a powerful predictor of SBO.
Target lesion characteristics, stent type, and clinical characteristics do not
correlate with SBO.
